SRRA News and Press, Sierra Oncology Inc. From 04/13/22

Gainers: Kaleido Biosciences (KLDO) +114%. Antares Pharma (ATRS) +49%. Sierra Oncology (SRRA) +39%. HighPeak Energy (HPK) +29%. Biofrontera (BFRI) +30%. Turning Point Therapeutics (TPTX) +27%. Aterian (ATER) +25%. Hallador Energy (HNRG) +23%. Crinetics Pharmaceutical (CRNX) +20%. Exscientia (...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Creatd (NASDAQ: CRTD ) stock is gaining on Wednesday following news of a deal for wellness beverage subsidiary Dune Glow Remedy. Source: Konmac / Shutterstock.com According to a press release , Dune is now av...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kaleido Biosciences (NASDAQ: KLDO ) stock is rocketing higher on Wednesday but anyone considering a stake in the company will want to keep an eye on April 28. Source: arfa adam / Shutterstock.com That’s...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Late-stage biopharmaceutical company Sierra Oncology (NASDAQ: SRRA ) is up big today on news that GlaxoSmithKline (NYSE: GSK ) will purchase the business . Indeed, SRRA stock is up a massive 38% so far today on...

Stock Market Today Mid-Morning Updates On Wednesday, the Dow Jones Industrial Average is up by 40 points after the release of the producer price index (PPI) for March. The index indicates that the prices of goods and services producers receive rose at the fastest pace since reco...

Gainers: Antares Pharma ATRS +49%. Sierra Oncology SRRA +38%. CTI BioPharma (CTIC) +8%. Ikena Oncology IKNA +8%. Modular Medical (MODD) +4%. Losers: NanoString Technologies NSTG -31%. Bio-Path (BPTH) -17%. BioCardia (BCDA) -14%. Biod...

Shares of rare-cancer company Sierra Oncology (NASDAQ: SRRA) jumped by as much as 38% in premarket trading Wednesday morning. The drugmaker's stock is surging this morning in response to a $1.9 billion buyout agreement with U.K. pharma giant GlaxoSmithKline (NYSE: GSK) ....

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday! Source: f11photo/Shutterstock.com Moving stocks this morning are earnings reports, acquisition deals, insider buy...

Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submissi...

Sierra Oncology Inc. (NASDAQ:SRRA) traded at a new 52-week high today of $36.77. Approximately 2.9 million shares have changed hands today, as compared to an average 30-day volume of 339,000 shares. Sierra Oncology Inc. share prices have moved between a 52-week high of $36.77 and a 52-we...